1M6MYTD1Y5YMAX
Loading quotes...
Forecast
| Buy |
5 |
| Hold |
3 |
| Sell |
0 |
News Go to news feed
There is currently no news available for this company. We are working on adding more providers to change this.
Financials
| (EUR) | Sep 2025 | |
|---|---|---|
| Revenue | 171.28K | - |
| Gross profit | 171.28K | - |
| Net profit | -5.09M | - |
| EBITDA | -2.83M | - |
Fundamentals
| Metric | Value |
|---|---|
Market capitalization | €1.85M |
Number of shares | 5.23M |
52-week high/low | €14.76 - €0.27 |
| Dividends | No |
Beta | 1.79 |
P/E ratio | -0.07 |
PEG ratio | 0.00 |
P/B ratio | -0.02 |
P/S ratio | 0.43 |
Company profile
| Name | CLEARSIDE BIOMED. O.N. |
| CEO | George Lasezkay |
| Employees | 32 |
Discover assets
Shareholders of CLEARSIDE BIOMED. O.N. also invest in the following assets
